News | April 11, 2026
Zydus improves ESG rating to 68, up from 66 last year
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Subscribe To Our Newsletter & Stay Updated
